ATLAS fair value
ATLAS has no fair value for this stock today.
Bon Natural Life stock price today, ATLAS forecast and fair value
Basic Materials · Specialty Chemicals · NASDAQ
Prices as of Oct 27, 2026 · USD
ATLAS has no fair value for this stock today.
48%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS's model gives Bon Natural Life a 48% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between $1.04 and $1.24; in 9 out of 10, between $0.89 and $1.45. Estimated annual volatility is 30%.
ATLAS does not publish a fair value for BON right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks BON has traded between $0.95 and $2.06. Today it is 44.7% below that high and 20% above its low.
On the business: revenue fell 21.7% year over year; net margin is 11.0%.
Its beta is -0.24: it tends to move less than the market.
Bon Natural Life Ltd. Class A Ordinary Shares represents the equity of Bon Natural Life Limited, a company focused on bio-ingredient solutions for the natural health, functional food, personal care, cosmetic, and related industries.
Want to see everything about Bon Natural Life?
Get started →Plans from €3.99 a month.
Bon Natural Life Ltd. Class A Ordinary Shares represents the equity of Bon Natural Life Limited, a company focused on bio-ingredient solutions for the natural health, functional food, personal care, cosmetic, and related industries.
48%: close to a coin flip. In half of the simulated outcomes, BON ends the month between $1.04 and $1.24.
ATLAS estimates annual volatility at 30%. In a typical month, half of the outcomes end between $1.04 and $1.24.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy